- •Contents
- •Learning Objectives
- •Accreditation and Credit Designation Statements
- •Activity Instructions
- •Instructions for cme Credit
- •Nei Disclosure Policy
- •Individual Disclosure Statements
- •Disclosure of Off-Label Use
- •Disclaimer
- •Sponsorship Information
- •Support
- •Introduction
- •List of Icons
- •Abbreviations used in this book
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •References
- •Guide to cme Posttest Questions Release/Expiration Dates
- •Index of Drug Names
- •Index of Case Studies
Individual Disclosure Statements
Author/Developer
Stephen M. Stahl, MD, PhD
Adjunct Professor, Department of Psychiatry, University of California, San Diego School of Medicine
Honorary Visiting Senior Fellow, University of Cambridge, UK
Grant/Research: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Cephalon, Dainippon Sumitomo, Forest, Lilly, Lundbeck, Novartis, Pamlab, Pfizer, Pfizer Canada, Pharmasquire, sanofi-aventis, Schering-Plough, Sepracor, Shire, Wyeth
Consultant/Advisor: Allergan, Alkermes, Arena, AstraZeneca, BioMarin, Biovail, Boehringer Ingelheim, Bristol-Myers Squibb, CeNeRx, Covance, Cypress Bioscience, Dainippon Sumitomo, Eisai, Forest, GenOmind, GlaxoSmith Kline, Janssen, Jazz, Labopharm, Lilly, Lundbeck, Marinus, MEDACorp/Leerink Swann, Meiji, Merck, Neuronetics, Novartis, Otsuka America, Pamlab, Pfizer, Pfizer Canada, PGxHealth/Clinical Data, Pierre Fabre, Prexa, Propagate, Rexahn, Royalty, sanofi-aventis, Schering-Plough, Sepracor, Servier, Shire, SK, Sofinnova, Solvay, Vanda, VIVUS, Wyeth
Speakers Bureau: Merck, Pfizer, Schering-Plough, Wyeth
Content Editors
Meghan Grady
Director, Content Development, Neuroscience Education Institute, Carlsbad, CA
No other financial relationships to disclose.
Debbi Ann Morrissette, PhD
Adjunct Professor, Biological Sciences, California State University, San Marcos
Medical Writer, Neuroscience Education Institute, Carlsbad, CA
No other financial relationships to disclose.
Peer Reviewers
Ronnie Gorman Swift, MD
Professor and Associate Chairman, Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla
Professor of Clinical Public Health, School of Public Health, New York; New York Medical College, Valhalla
Chief of Psychiatry and Associate Medical Director, Metropolitan Hospital Center, New York City
No other financial relationships to disclose.
Steven S. Simring, MD, MPH
Clinical Associate Professor, Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York City
No other financial relationships to disclose.
Owen Nichols, PsyD, MBA, NHA, CPM, ABPP, ABMP
President and CEO, NorthKey Community Care, Covington, KY
No other financial relationships to disclose.
Cheryl Raleigh-DuRoff, MN, ARNP
Clinical Adviser, University of Washington School of Nursing, Seattle
Consultant, Valley Medical Center, Psychiatry and Counseling Center, Renton, WA
Psychiatric ARNP and Counselor in Private Practice, Seattle, WA
No other financial relationships to disclose.
Disclosed financial relationships have been reviewed by the Neuroscience Education Institute CME Advisory Board to resolve any potential conflicts of interest. All faculty and planning committee members have attested that their financial relationships do not affect their ability to present well-balanced, evidence-based content for this activity.
Disclosure of Off-Label Use
This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not approved by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.
